B.Pharm Pharmaceutical Inorganic and Analytical Chemistry Important Questions PDF 

PHARMACEUTICAL INORGANIC AND ANALYTICAL CHEMISTRY – BP106T UNIT-WISE Important Questions, B.Pharma 1st Semester.

Unit – 1

1. Very Short Answers Questions

★ Q1.Define Pharmaceutical Analysis and state its primary qualitative and quantitative objectives.
Q2. What is the fundamental operational difference between qualitative and quantitative analysis?
★ Q3.Define a Primary Standard substance and state its essential pharmacopoeial purity threshold.
Q4. Why cannot Sodium Hydroxide (NaOH) be employed directly as a primary standard in titrimetry?
★ Q5.Define an Error in pharmaceutical analysis and express it in mathematical equation form.

Q6. What are Determinate (Systematic) Errors and what is their primary distinguishing characteristic?
Q7. What is a Blank Titration and how does it eliminate analytical titrant error?
★ Q8.Define a Pharmacopoeial Limit Test according to IP/BP standards.
Q9. What is the specific chemical role of dilute Nitric Acid (HNO₃) in the limit test for chloride?
Q10. What is the dual function of Potassium Sulphate (K₂SO₄) and alcohol in Barium Sulphate Reagent?
Q11. Why is a lead acetate cotton plug placed in the glass tube of the Gutzeit Arsenic apparatus?

2. Short Answer Questions

★ Q1.Enlist the ideal requirements of a primary standard substance with two examples each for acid-base and redox titrations.
Q2. Distinguish clearly between Accuracy and Precision along with their respective mathematical expressions.
★ Q3.Classify determinate (systematic) errors based on their root sources with practical laboratory examples.
Q4. Describe the standard analytical methods employed for minimizing systematic errors in quantitative assays.
★ Q5.State the official rules for identifying significant figures and rounding off analytical results in calculations.

Q6. Classify pharmaceutical impurities according to ICH Q3 guidelines and explain their regulatory importance.
★ Q7.Explain the principle, chemical reaction, and specific role of reagents in the Limit Test for Sulphate (IP).
Q8. Outline the principle, chemical reaction mechanism, and color development in the Limit Test for Iron (IP).
Q9. Explain the specific chemical functions of Citric Acid, Thioglycolic Acid, and Ammonia in the limit test for iron.
Q10. Describe the principle, reaction, and extraction mechanism involved in the Limit Test for Lead (IP).
Q11. Summarize the general principle of the Limit Test for Heavy Metals and contrast Method A with Method B of the IP.
Q12. Explain the principle and chemical pretreatment in the Modified Limit Test for Chloride in Potassium Permanganate (KMnO₄).

3. Long Answer Questions

★ Q1.Elaborate on the various sources and types of impurities present in pharmaceutical substances with underlying mechanisms, practical drug examples, and their clinical/regulatory importance.
★ Q2.Explain the principle, sequential chemical reactions, and complete procedure of the Limit Test for Arsenic (IP/BP) with a neat, fully labeled diagram of the Gutzeit apparatus.
Q3. Discuss the major classifications of techniques used in pharmaceutical analysis and elaborate on the various methods of expressing the strength of solutions with mathematical calculations.

★ Q4.Describe in detail the principle, chemical reactions, role of masking agents, and comparative procedure of the Limit Test for Lead (IP) using dithizone extraction.
Q5. Write an exhaustive note on Errors in pharmaceutical analysis: detail the classification of systematic vs. random errors, statistical measures of precision, and standard methods of minimizing errors.
Q6. Explain the rationale for modified limit tests and describe the detailed modification procedures for Chloride and Sulphate in colored (KMnO₄), effervescent (NaHCO₃), and insoluble minerals.

Unit – 2

1. Very Short Answers Questions

★ Q1.Define an Arrhenius Acid and Base with their respective aqueous chemical dissociation reactions.
Q2. Define a Conjugate Acid-Base Pair according to the Brønsted-Lowry concept with a chemical example.
★ Q3.Define Lewis Acid and Base based on the electronic concept and give one pharmaceutical coordinate adduct.
Q4. Define pH and pOH and state their fundamental mathematical relationship at 25°C.
★ Q5.Define a Buffer Solution and differentiate between acidic and basic buffers with standard examples.
Q6. What is Buffer Capacity (β) according to Donald D. Van Slyke’s mathematical definition?

Q7. Define an Isotonic Solution and state the exact freezing point depression value of human blood plasma.
Q8. Define the Sodium Chloride Equivalent (E-value) of a drug substance used in tonicity adjustment.
★ Q9.Identify the principal extracellular cation and principal intracellular cation with their normal plasma values.
Q10. Name the titrant, indicator, and medium used in the official pharmacopoeial assay of Calcium Chloride.
Q11. Why is the direct intravenous (IV) bolus or push administration of Potassium Chloride strictly contraindicated?
Q12. State the total osmolarity (in mOsm/L) of the official WHO / UNICEF Reduced Osmolarity ORS formulation.

2. Short Answer Questions

★ Q1.Compare Arrhenius, Brønsted-Lowry, and Lewis theories of acids and bases with definitions, scope, and limitations.
Q2. Discuss the pharmaceutical significance of pH in drug stability, aqueous solubility, and biological drug absorption.
★ Q3.Explain the mechanism of buffer action in an Acetate Buffer (CH₃COOH / CH₃COONa) against added strong acid and base.
Q4. Derive the Henderson-Hasselbalch buffer equation for calculating the pH of a weak acid and its conjugate base.
Q5. Calculate the pH of an acetate buffer containing 0.20 M Sodium Acetate and 0.10 M Acetic Acid (Given: pKa = 4.76).
★ Q6.Differentiate between Isotonic, Hypertonic, and Hypotonic solutions and explain their morphological effects on RBCs.
Q7. Describe the Cryoscopic (Freezing Point Depression) method for adjusting the isotonicity of pharmaceutical solutions.

Q8. Outline the physiological distribution of body fluids (ICF vs. ECF) and enlist the key functions of Sodium and Potassium.
Q9. Enlist the physiological functions and clinical manifestations of deficiency and excess of Calcium (Ca²⁺) and Magnesium (Mg²⁺).
★ Q10.Explain the principle, chemical reactions, and role of nitrobenzene in the assay of Sodium Chloride by Modified Volhard’s method.
Q11. Describe the preparation, properties, and complexometric assay principle of Calcium Chloride (CaCl₂·2H₂O).
Q12. Give the composition of WHO Reduced Osmolarity ORS (g/L and mmol/L) and explain the SGLT-1 cotransport mechanism.
★ Q13.Describe the Carbonic Acid – Bicarbonate buffer system in blood and explain why a 20:1 ratio maintains pH 7.40.
Q14. Explain the ROME rule for arterial blood gas analysis and distinguish between Metabolic and Respiratory Acidosis.

3. Long Answer Questions

★ Q1.Elaborate on the theories of acids and bases (Arrhenius, Brønsted-Lowry, Lewis) with chemical dissociation equations, conjugate pairs, Lewis adducts, and pharmaceutical scope.
★ Q2.Derive the Henderson-Hasselbalch equation for acidic and basic buffer systems. Define buffer capacity (β), state the condition for maximum buffer capacity, and discuss pharmaceutical buffer applications.
★ Q3.Discuss the concept of tonicity and osmotic equilibrium, consequences of hypotonic and hypertonic solutions on RBCs, and detail the various methods of adjusting isotonicity (Cryoscopic, NaCl equivalent, White-Vincent).

Q4. Detail the major physiological ions (Na⁺, K⁺, Ca²⁺, Mg²⁺, Cl⁻, HCO₃⁻, HPO₄²⁻), their normal plasma reference concentrations, physiological roles, and associated clinical deficiency and excess states.
★ Q5.Write comprehensive monographs on electrolytes used in replacement therapy: (a) Sodium Chloride (Assay by Modified Volhard’s method), (b) Calcium Chloride (Complexometric assay), and (c) WHO Reduced Osmolarity ORS.
Q6. Explain the physiological regulation of acid-base balance in the human body through chemical buffer systems, respiratory regulation, and renal mechanisms, along with clinical acid-base disorders.

Unit – 3

1. Very Short Answers Questions

★Q1.Define an Acid-Base Indicator and state Ostwald’s ionization theory of indicators.
Q2. State the structural premise of the Quinonoid Theory of acid-base indicators.
Q3. Why is phenolphthalein an unsuitable indicator for titrating a strong acid against a weak base?
★Q4.What is the Leveling Effect of Water and how does it restrict titrations of very weak bases?
Q5. Define a Protogenic Solvent with two standard pharmaceutical examples.
Q6. Why is acetic anhydride added during the preparation of 0.1 N acetous perchloric acid?
★Q7.Define Von Weimarn’s Ratio (Relative Supersaturation) and state its mathematical formula.

Q8. What is Digestion (Ostwald Ripening) in gravimetric analysis and what is its primary benefit?
Q9. Name the primary indicator, pH medium, and endpoint color observed in Mohr’s Method.
★Q10.Why is nitrobenzene added during the assay of chloride by the Modified Volhard’s method?
Q11. Explain the basic mechanism of action of an Adsorption Indicator in Fajans method.
Q12. Why does Disodium EDTA react with metal ions strictly in a 1:1 molar ratio regardless of metal valency?
★Q13.Define a Hexadentate Ligand and identify the donor coordination atoms in Disodium EDTA.
Q14. What essential stability condition must be fulfilled between Metal-EDTA and Metal-Indicator complexes?

Q15. Define a Masking Agent in complexometric titration with one practical example.
Q16. How does adjusting the pH to ~12 using 5 M NaOH mask Mg²⁺ during the assay of Calcium Gluconate?
★Q17.Why is dilute Sulphuric Acid (H₂SO₄) used to acidify potassium permanganate titrations instead of HCl or HNO₃?
Q18. Why is Potassium Permanganate (KMnO₄) termed a Self-Indicator?
Q19. State two key analytical advantages of Cerimetry over Permanganometry.
★Q20.Why is freshly prepared starch indicator added only near the endpoint in iodometry?
Q21. State the primary operational difference between Iodimetry and Iodometry.
Q22. Explain how the endpoint is detected in Andrews Titration using Potassium Iodate (KIO₃).

2. Short Answer Questions

★Q1.Compare Ostwald’s Theory and Quinonoid Theory of acid-base indicators with chemical examples.
Q2. Explain the preparation and standardization of 0.1 M Hydrochloric Acid (HCl) using primary standard Na₂CO₃.
★Q3.Discuss the neutralization curve of Weak Acid vs Strong Base and explain why Methyl Orange is unsuitable.
Q4. Describe the principle, reaction, and procedure for the pharmacopoeial Assay of Ammonium Hydroxide.
Q5. Explain the preparation and standardization of 0.1 M Sodium Hydroxide against primary standard KHP.
★Q6.Classify non-aqueous solvents (protogenic, protophilic, amphiprotic, aprotic) with examples and analytical roles.

Q7. Describe the preparation and standardization of 0.1 N Acetous Perchloric Acid (HClO₄).
Q8. Outline the principle, chemical reaction, and equivalence factor for the estimation of Sodium Benzoate.
★Q9.Compare Mohr’s, Volhard’s, and Fajans methods of precipitation titration regarding medium, indicator, and endpoints.
Q10. Explain the significance of Von Weimarn’s ratio and how experimental conditions are optimized in gravimetry.
Q11. Describe the principle and steps involved in the estimation of Barium Sulphate by gravimetry.
★Q12.Explain the concepts of Masking and Demasking agents in complexometry with suitable chemical examples.

Q13. Classify complexometric titrations into Direct, Back, Replacement, and Indirect titrations with examples.
Q14. Explain the principle, buffer, indicator, and color transitions in the Assay of Magnesium Sulphate.
★Q15.Differentiate between Iodimetry and Iodometry regarding titrant, analyte, reaction type, and starch timing.
Q16. Explain the standardization of 0.1 N Potassium Permanganate (KMnO₄) against Oxalic Acid at 60–70°C.
★Q17.Explain the principle, high HCl concentration role, and two-phase endpoint in Andrews Titration (KIO₃).
Q18. Describe the principle of Cerimetry, its 1-electron transfer mechanism, and the Ferroin indicator transition.

3. Long Answer Questions

★Q1.Elaborate on the theories of acid-base indicators and discuss the neutralization curves, pH jumps, and indicator selection for all four classes of acid-base titrations.
Q2. Explain in detail the preparation, standardization, and reaction equations for 0.1 M HCl and 0.1 M NaOH, and describe the pharmacopoeial assay of Ammonium Hydroxide.
★Q3.Discuss the principle and necessity of Non-Aqueous Titrations. Classify non-aqueous solvents, detail the preparation/standardization of 0.1N HClO₄, and describe the assay of Sodium Benzoate.
Q4. Write a detailed note on Non-Aqueous Alkalimetry: solvents, preparation and standardization of Sodium Methoxide, and estimation of weakly acidic pharmaceuticals.

★Q5.Explain the fundamental principles and sequential steps involved in Gravimetric Analysis, detail the Von Weimarn ratio, and describe the estimation of Barium Sulphate.
★Q6.Provide an exhaustive comparative account of Argentometric Titrations: Mohr’s method, Volhard’s method, Modified Volhard’s method, and
Q7. Discuss the complete laboratory procedure, chemical reactions, role of dilute HCl, ignition conditions, and calculation factors for the gravimetric determination of Barium Sulphate.
★Q8.Describe the chemistry of Disodium EDTA, its hexadentate nature, classification of complexometric titrations, metal ion indicators, and the assay of Calcium Gluconate.

Q9. Explain the mechanisms of Masking and Demasking in complexometry (complexation, precipitation, redox) and describe the preparation and standardization of 0.05 M Disodium EDTA.
★Q10.Explain the principles of Permanganometry and Cerimetry. Discuss why H₂SO₄ is mandatory for KMnO₄, their half-cell reactions, standardization procedures, and relative merits.
★Q11.Differentiate comprehensively between Iodimetry and Iodometry. Explain their chemical reactions, standardization of sodium thiosulphate, and starch indicator mechanism.
Q12. Discuss the principle, chemical mechanism, and procedure of Titrations with Potassium Iodate (Andrews Titration), detailing the role of 4–9M HCl and the two-phase endpoint.

Unit – 4

1. Very Short Answers Questions

★Q1.Define Gastric Acidifiers and name the primary clinical condition treated by them.
Q2. State the official percentage strength (% w/w) and specific gravity of Dilute Hydrochloric Acid IP.
★Q3.Define an Antacid and state the optimum pH window required for gastric acid buffering.
Q4. Why is Sodium Bicarbonate classified pharmacologically as a Systemic Antacid?
Q5. What is the major dose-limiting gastrointestinal adverse effect of Aluminium Hydroxide Gel?
★Q6.State the primary therapeutic rationale for combining Aluminium Hydroxide and Magnesium Hydroxide in antacids.

Q7. Define Saline Cathartics and state their primary physiological mechanism in promoting bowel evacuation.
Q8. Write the chemical formula, official name, and popular synonym of Rochelle Salt.
Q9. Explain the dual therapeutic function of Magnesium Trisilicate in peptic ulcer management.
★Q10.Enlist the three primary biochemical mechanisms of action of Inorganic Topical Antimicrobials.
Q11. What is the exact percentage strength (% w/v) corresponding to “20 Volume” Hydrogen Peroxide IP?
Q12. Define Available Chlorine in Chlorinated Lime IP and state its minimum pharmacopoeial specification.
Q13. Why is Potassium Iodide (KI) incorporated into the formulation of official aqueous iodine solutions?
Q14. Define the Physical Half-Life (T1/2) of a radioactive isotope and write its mathematical equation.
★Q15.Why must high-energy pure beta emitters such as Phosphorus-32 (³²P) never be shielded directly with lead?
Q16. State the primary diagnostic nuclear imaging application and half-life of Technetium-99m (⁹⁹ᵐTc).

2. Short Answer Questions

★Q1.Explain the preparation, assay principle, and titration reaction of Dilute Hydrochloric Acid IP.
Q2. Describe the synthesis, assay principle, and physiological mechanism of Sodium Acid Phosphate IP.
★Q3.Enlist the ideal properties of an antacid and differentiate between systemic and non-systemic antacids.
Q4. Discuss the clinical rationale for antacid combinations and state the roles of simethicone and sodium alginate.
★Q5.Detail the Solvay industrial synthesis, assay titration principle, and clinical limitations of Sodium Bicarbonate IP.
Q6. Describe the preparation, gastric neutralization buffering, and complexometric back-titration assay of Aluminium Hydroxide Gel IP.
★Q7.Explain the general osmotic mechanism of action of Saline Cathartics and describe the assay of Milk of Magnesia [Mg(OH)₂].

Q8. Describe the preparation, chemical structure, and medicinal applications of Sodium Potassium Tartrate (Rochelle Salt).
Q9. Classify inorganic topical antimicrobials based on chemical mechanisms: Oxidation, Halogenation, and Protein Precipitation.
★Q10.Explain the preparation, permanganometric assay, storage requirements, and volume strength of Hydrogen Peroxide IP.
Q11. Describe the Hasenclever synthesis, iodometric assay principle, and sanitary applications of Chlorinated Lime IP.
Q12. Compare official iodine formulations: Lugol’s Solution, Mild Iodine Tincture, and Povidone-Iodine IP.
Q13. Differentiate between Alpha (α), Beta (β), and Gamma (γ) radiations regarding charge, ionizing power, and penetration depth.
Q14. Explain the ALARA principle in radiation protection and contrast the shielding requirements for Gamma vs Beta emitters.

3. Long Answer Questions

★Q1.Define Antacids. Elaborate on the ideal properties of antacids, classify systemic vs non-systemic agents with examples, and discuss the comprehensive rationale for formulating antacid combinations.
★Q2.Write exhaustive pharmacopoeial monographs on: (a) Sodium Bicarbonate IP (Solvay process, neutralization assay, adverse effects), and (b) Aluminium Hydroxide Gel IP (Preparation, buffering mechanism, complexometric back-titration).

Q3. Classify agents promoting bowel movements. Detail the osmotic mechanism of Saline Cathartics and provide complete monographs on Magnesium Hydroxide IP and Sodium Potassium Tartrate IP.
★Q4.Discuss the biochemical mechanisms of Inorganic Topical Antimicrobial Agents. Detail the preparation, chemical reactions, assay principles, and medicinal uses of Hydrogen Peroxide IP and Chlorinated Lime IP.
Q5. Explain the chemistry of iodine solubilization and provide an exhaustive comparative account of official pharmaceutical iodine preparations: Lugol’s Solution, Iodine Tinctures, and Povidone-Iodine IP.

★Q6.Define radioactivity and decay kinetics. Tabulate the properties of nuclear radiations and elaborate on the production, radiation properties, and clinical applications of Sodium Iodide I-131 and Technetium-99m.
Q7. Discuss the clinical and industrial applications of Cobalt-60 and Phosphorus-32, explaining the phenomenon of Bremsstrahlung radiation and its shielding considerations.
★Q8.Explain the principles of radiation protection (ALARA), safe handling protocols in radiopharmacy, storage criteria, waste disposal methods (DIS, Dilute & Disperse, Concentrate & Contain), and AERB/BARC regulatory guidelines.

Unit – 5

1. Very Short Answers Questions

★Q1.Define Expectorants and state their primary physiological therapeutic role in productive cough.
Q2. Why does an aqueous solution of Potassium Iodide (KI) turn yellow or brownish upon prolonged atmospheric exposure?
★Q3.State the assay principle and titrant used in the Formol Titration of Ammonium Chloride IP.
Q4. Define Emetics and state two critical clinical situations where their administration is strictly contraindicated.
★Q5.What is the specific role of Potassium Thiocyanate (KCNS) in the indirect iodometric assay of Copper Sulphate IP?

Q6. Define Haematinics and name the primary enterocyte transporter protein responsible for non-heme iron uptake.
Q7. Why is metallic iron scrap maintained in slight excess during the industrial preparation of Ferrous Sulphate IP?
★Q8.Name the titrant, indicator, and sharp endpoint color transition observed in the official Cerimetric assay of Ferrous Sulphate.
Q9. Explain the biochemical mechanism by which Sodium Thiosulphate acts as a specific antidote in cyanide poisoning.

2. Short Answer Questions

★Q1.Differentiate between Reflex (Sedative) Expectorants and Direct-Acting Expectorants with mechanisms and examples.
Q2. Describe the physical properties, Andrews titration assay principle, and clinical applications of Potassium Iodide (KI).
★Q3.Explain the industrial synthesis, thermal dissociation, and Formol Titration assay of Ammonium Chloride IP (NH₄Cl).
Q4. Discuss the physiological mechanisms of Ammonium Chloride as a reflex expectorant and as a systemic acidifier.
Q5. Explain why emetics are strictly contraindicated in corrosive poisoning, hydrocarbon ingestion, and comatose patients.

Q6. Describe the commercial synthesis, stepwise thermal dehydration, and reaction with ammonia of Copper Sulphate IP.
★Q7.Explain the principle, sequential chemical reactions, and calculation factor in the iodometric assay of Copper Sulphate IP.
Q8. Outline the physiological pathway of iron absorption, plasma transferrin transport, and cellular storage in ferritin.
Q9. Describe the preparation, atmospheric oxidation, and cerimetric redox assay of Ferrous Sulphate IP (FeSO₄·7H₂O).
★Q10.Classify Antidotes into Physiological, Chemical, Mechanical, and Universal with clinical examples and specific poisons.
Q11. Describe the preparation, acid decomposition reaction, and direct iodimetric assay of Sodium Thiosulphate IP.

3. Long Answer Questions

★Q1.Define Expectorants. Classify them with mechanisms of action and provide a comprehensive pharmacopoeial monograph on Ammonium Chloride IP covering industrial synthesis, physical and chemical properties, Formol Titration assay principle with balanced equations, and medicinal applications.
★Q2.Write an exhaustive pharmacopoeial monograph on Copper Sulphate IP (CuSO₄·5H₂O) covering preparation, chemical properties, detailed indirect iodometric redox assay with the specific role of Potassium Thiocyanate (KCNS), and explain why its historical use as an emetic and phosphorus antidote is obsolete.

Q3. Discuss the physiological pathway of iron absorption, transport, and storage. Detail the commercial synthesis, physical properties, atmospheric degradation, and Cerimetric assay of Ferrous Sulphate IP, comparing its clinical tolerance with Ferrous Gluconate.
★Q4.Define Poison and Antidote. Provide an exhaustive classification of antidotes with modes of action and examples. Elaborate on the biochemistry of Cyanide Poisoning (Histotoxic Anoxia), the complete Nitrite-Thiosulphate Antidote Cascade, and the direct iodimetric assay of Sodium Thiosulphate IP.

📌 Questions marked with (★) represent high-frequency university exam as well as internal exam questions derived from PCI semester evaluation trends. Students must prioritize these questions for core concept clarity and good scoring in exam.